⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Joseph LowyMD

Pulmonary Disease · New York, NY 10016

NPI: 1699855387

Share:

36

🟠 Elevated

Risk Flags

Extreme opioid rate vs specialty peers90th percentile opioid prescribingHigh long-acting opioid rate vs peers

Risk indicators are statistical patterns, not allegations. Learn more

138

Total Claims

$13K

Drug Cost

30

Beneficiaries

$420

Cost/Patient

Risk Score Breakdown 36/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Long-acting opioid rate+8
Opioid rate (national percentile)+3

Score components are additive. Read full methodology

Peer Comparison vs. 9,082 Pulmonary Disease providers

-92%

Cost per patient vs peers

$420 vs $5,138 avg

-63%

Brand preference vs peers

22.5% vs 61.4% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

Opioid Prescribing

34.8%

Opioid Rate

48

Opioid Claims

$2,414

Opioid Cost

47.9%

Long-Acting Rate

This provider's opioid prescribing rate of 34.8% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

78% generic

Brand: 31 claims · $6,051

Generic: 107 claims · $6,535

Patient Profile

78

Avg Age

63%

Female

3.25

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About